cycloheximide has been researched along with Acute Confusional Senile Dementia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chávez-Gutiérrez, L; Comaposada-Baró, R; Escribano-Saiz, JJ; Franco, ML; García-Carpio, I; Vilar, M | 1 |
| Abraham, WC; Hughes, SM; Kweon, D; Mockett, BG; Morrissey, JA; Ohline, SM; Singh, A; Tate, WP | 1 |
| da Cruz e Silva, EF; da Cruz E Silva, OA; Rebelo, S; Vieira, SI | 1 |
| Cadman, ED; Lee, CM; Witte, DG | 1 |
| Alkon, DL; Favit, A; Grimaldi, M; Nelson, TJ | 1 |
| Grammas, P; Moore, P; Weigel, PH | 1 |
| Camandola, S; Mattson, MP; Poli, G | 1 |
7 other study(ies) available for cycloheximide and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
TrkA-mediated endocytosis of p75-CTF prevents cholinergic neuron death upon γ-secretase inhibition.
Topics: Alzheimer Disease; Amino Acid Motifs; Amyloid Precursor Protein Secretases; Cell Death; Cholinergic Neurons; Cycloheximide; Endocytosis; Humans; Ligands; MAP Kinase Signaling System; Protein Binding; Protein Interaction Domains and Motifs; Protein Multimerization; Proteolysis; Receptor, Nerve Growth Factor; Receptor, trkA | 2021 |
A C-terminal peptide from secreted amyloid precursor protein-α enhances long-term potentiation in rats and a transgenic mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Bungarotoxins; CA1 Region, Hippocampal; Cycloheximide; Dose-Response Relationship, Drug; Gene Expression; Long-Term Potentiation; Male; Mice; Mice, Transgenic; Peptide Fragments; Rats | 2019 |
A model system to study intracellular trafficking and processing of the Alzheimer's amyloid precursor protein.
Topics: Alzheimer Disease; Amino Acid Sequence; Amino Acids; Amyloid beta-Protein Precursor; Animals; Cells, Cultured; Chlorocebus aethiops; COS Cells; Cycloheximide; Green Fluorescent Proteins; Humans; Microscopy, Fluorescence; Models, Biological; Molecular Sequence Data; Mutagenesis; Phosphorylation; Protein Synthesis Inhibitors; Recombinant Fusion Proteins; Signal Transduction | 2004 |
Regulation of the release of interleukin-6 from human astrocytoma cells.
Topics: Adenylyl Cyclases; Alzheimer Disease; Astrocytoma; Calcium; Cycloheximide; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Glial Fibrillary Acidic Protein; Histamine; Humans; Indomethacin; Inositol Phosphates; Interleukin-1; Interleukin-6; Kinetics; Protein Kinase C; Substance P; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1994 |
Alzheimer's-specific effects of soluble beta-amyloid on protein kinase C-alpha and -gamma degradation in human fibroblasts.
Topics: Acetylcysteine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Blotting, Western; Brain; Cells, Cultured; Cycloheximide; Fibroblasts; Humans; Isoenzymes; Peptide Fragments; Protein Kinase C; Protein Kinase C-alpha; Protein Synthesis Inhibitors; Rats; Tetradecanoylphorbol Acetate | 1998 |
Microvessels from Alzheimer's disease brains kill neurons in vitro.
Topics: Alzheimer Disease; Animals; Brain; Capillaries; Cell Death; Coculture Techniques; Culture Media, Conditioned; Cycloheximide; Humans; Nerve Degeneration; Neurons; PC12 Cells; Rats | 1999 |
The lipid peroxidation product 4-hydroxy-2,3-nonenal inhibits constitutive and inducible activity of nuclear factor kappa B in neurons.
Topics: Aldehydes; Alzheimer Disease; Animals; Apoptosis; Cell Survival; Cells, Cultured; Cerebral Cortex; Cycloheximide; Cysteine Proteinase Inhibitors; Enzyme Inhibitors; Lipid Peroxidation; Nerve Degeneration; Neurons; NF-kappa B; Okadaic Acid; Protein Synthesis Inhibitors; Rats; Stroke; Transcription Factor AP-1; Vanadates | 2000 |